Metagenics Canada, in consultation with Health Canada, is voluntarily recalling its natural health product “Spectrazyme” – a digestive aid – due to a possible contamination with chloramphenicol, an antibiotic that may pose serious health risks to consumers. Chloramphenicol is associated with a rare risk of aplastic anemia, a serious blood disorder that can be fatal. This reaction is unpredictable and not related to a specific dose of chloramphenicol.
Chloramphenicol is a prescription drug and should only be used under medical supervision in adults and children after careful consideration of the risks associated with it use. Other side effects that can be associated with chloramphenicol include allergic reactions in people who have sensitivity to the medication, and effects on the bone marrow leading to decreased blood cells. In addition, it should not be used in pregnant or lactating women.
Canadians who have used this product. The company has not received any reports of adverse reactions associated with this product.
Health Canada is monitoring the recall of “Spectrazyme” by the company.
According to the company, testing of one of the raw materials used to produce this product identified the presence of chloramphenicol.
To report suspected adverse reaction to these or other health products, please contact Health Canada’s Canada Vigilance Program toll-free at 1-866-234-2345, or complete a
Canada Vigilance Reporting Form and send to us using one of these methods:
-
Fax: 1-866-678-6789
-
Internet: www.healthcanada.gc.ca/medeffect
-
Mail: Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, ON, Address Locator 0701E
K1A 0K9
Health Canada
(613) 957-2983
(613) 957-2991
1-866 225-0709